Andy I. Chen
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 5%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 22
- Oncology 19
- CAR-T cell therapy research 9
- Viral-associated cancers and disorders 6
- HER2/EGFR in Cancer Research 5
- Co-authors
- Arlene H. Sharpe (3 shared papers)Veronika Bachanová (10 shared papers)Anna Sureda (5 shared papers)Craig H. Moskowitz (6 shared papers)Muneer H. Abidi (7 shared papers)Jerzy Hołowiecki (7 shared papers)Jan Walewski (7 shared papers)Tamás Masszi (7 shared papers)
- Journals
- Blood (11 papers)Journal of Clinical Oncology (6 papers)Biology of Blood and Marrow Transplantation (4 papers)Blood Advances (3 papers)Immunity (1 paper)
- Partner nations
- United StatesItalyPoland
In The Last Decade
Andy I. Chen
36 papers receiving 1.5k citations
Andy I. Chen's Hit Papers
Peers
Comparison fields: 5 of 71
- Pathology and Forensic Medicine 829
- Oncology 797
- Genetics 278
- Immunology 552
- Neurology 284
Countries citing papers authored by Andy I. Chen
This map shows the geographic impact of Andy I. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy I. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy I. Chen more than expected).
Fields of papers citing papers by Andy I. Chen
This network shows the impact of papers produced by Andy I. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy I. Chen. The network helps show where Andy I. Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Andy I. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2015 | 477 |
| 2 | 1999 | 254 | |
| 3 | 2018 | 156 | |
| 4 | 2019 | 93 | |
| 5 | 2002 | 93 | |
| 6 | 2003 | 89 | |
| 7 | 2008 | 80 | |
| 8 | 2018 | 67 | |
| 9 | 2014 | 22 | |
| 10 | 2015 | 21 | |
| 11 | 2015 | 17 | |
| 12 | 2013 | 16 | |
| 13 | 2022 | 14 | |
| 14 | 2017 | 14 | |
| 15 | 2024 | 13 | |
| 16 | 2013 | 13 | |
| 17 | 2016 | 12 | |
| 18 | 2014 | 11 | |
| 19 | 2012 | 11 | |
| 20 | 2008 | 8 |
About Andy I. Chen
Andy I. Chen is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Hematology, having authored 38 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (9 papers), CAR-T cell therapy research (9 papers), Viral-associated cancers and disorders (6 papers), Cutaneous lymphoproliferative disorders research (6 papers), HER2/EGFR in Cancer Research (5 papers), Immune Cell Function and Interaction (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (829 citations), Oncology (797 citations), Genetics (278 citations), Immunology (552 citations) and Neurology (284 citations). Andy I. Chen has collaborated with scholars based in United States, Italy and Poland. Frequent co-authors include Arlene H. Sharpe, Veronika Bachanová, Anna Sureda, Craig H. Moskowitz, Muneer H. Abidi, Jerzy Hołowiecki, Jan Walewski, Tamás Masszi, John Sweetenham and Patrick J. Stiff. Their work appears in journals such as Blood, Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation, Blood Advances and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.